A new drug developed by Merck shows promise for the treatment of Alzheimer's disease. Verubecestat, which is currently under clinical trial, is said to halt the beta amyloid plaque formation in brain.
Merck Clears Clinical Trial Milestone, Shows Promise With Alzheimer's Drug Verubecestat
Tech Times - 3 Nov 2016 16:56
A new drug developed by Merck shows promise for the treatment of Alzheimer's disease. Verubecestat, which is currently under clinical trial, is said to halt the beta amyloid plaque formation in brain.
Share this Article
Recommended